Cardiovascular Risk In White-coat and Sustained Hypertensive Patients

By Celis Hilde   Staessen Jan A.   Thijs Lutgarde   Buntinx Frank   De Buyzere Marc   Hond Elly Den   Fagard Robert H.   O'Brien Eoin T.  

Blood Pressure, Vol. 11, Iss. 6, 2002-11 ,pp. : 352-356

Informa Healthcare

Access to resources Recommend Favorite

Target organ damage and changes in arterial compliance in white coat hypertension. Is white coat innocent?

By Karter Y.   Çurgunlu A.   Altinişik S.   Ertürk N.   Vehi˙d S.   Mi˙hmanli İ.   Ayan F.   Kutlu A.   Arat A.   Öztürk E.   Erdi˙ne S.  

Blood Pressure, Vol. 12, Iss. 5-6, 2003-11 ,pp. : 307-313

Informa Healthcare

Access to resources Recommend Favorite

Can Pulse Pressure Predict the White-Coat Effect in Treated Hypertensive Patients?

By Yoon Hyun Ju   Ahn Youngkeun   Kim Kye Hun   Park Jong Chun   Park Jeong Bae   Park Chang Gyu   Youn Ho Joong   Choi Dong Ju   Shin Joon-Han   Kim Dong-Woon   Rim Se Joong   Bae Jang Ho   Kim Chong Wook  

Clinical and Experimental Hypertension, Vol. 34, Iss. 8, 2012-12 ,pp. : 555-560

Informa Healthcare

Access to resources Recommend Favorite

Atherogenesis in White Coat Hypertension

By  

Current Hypertension Reviews, Vol. 2, Iss. 2, 2006-05 ,pp. : 147-150

Bentham Science Publishers

Access to resources Recommend Favorite

C-reactive protein and nitric oxide level in patients with white coat hypertension

By Guven Aytekin   Tolun Fatma   Caliskan Mustafa   Ciftci Ozgur   Muderrisoglu Haldun  

Blood Pressure, Vol. 21, Iss. 5, 2012-10 ,pp. : 281-285

Informa Healthcare

Access to resources Recommend Favorite